Scientists have created artificial mini-placentas in the laboratory after nearly three decades of research, offering hope for tackling miscarriages, stillbirths and premature births as well as transform pregnancy research.
The new 'mini-placentas' are a cellular model of the early stages of the placenta and may shed light on mysteries surrounding the relationships between the placenta, the uterus and the foetus and enable research to prevent some infections passing from the mother's blood to the foetus as well as on Zika virus.
"These 'mini-placentas' built on decades of research will play an important role in helping us investigate events that happen during the earliest stages of pregnancy and yet have profound consequences for the life-long health of the mother and her offspring," explained Professor Graham Burton from the UK's University of Cambridge.
"The placenta supplies all the oxygen and nutrients essential for growth of the foetus, and if it fails to develop properly the pregnancy can sadly end with a low birthweight baby or even a stillbirth," he added.
For the new study, published in the journal Nature, the team grew organoids often referred to as 'mini-organs' using cells from villi -- tiny frond-like structures -- taken from placental tissue.
These trophoblast organoids are able to survive for long-term, are genetically stable and organise into villous-like structures that secrete essential proteins and hormones that would affect the mother's metabolism during pregnancy.
Further analysis showed that the organoids closely resemble normal first-trimester placentas, that they are able to record a positive response on an over-the-counter pregnancy test.
In addition, these organoids may also be used for screening the safety of drugs to be used in early pregnancy, to understand how chromosomal abnormalities may perturb normal development, and possibly even provide stem cell therapies for failing pregnancies.
The placenta is absolutely essential for supporting the baby as it grows inside the mother. When it doesn't function properly, it can result in serious problems, from pre-eclampsia to miscarriage, with immediate and lifelong consequences for both mother and child.
Efforts to grow human placental cells started over 30 years ago with Cambridge scientists studying cellular events of the first few weeks of pregnancy.
--IANS
rt/mag/bg
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
